ASH 2024 Highlights for MPN Patients - HealthTree for Myelofibrosis
[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

ASH 2024 Highlights for Myeloproliferative Neoplasm (MPN) Patients with Claire Harrison, MD

ASH 2024 Highlights for Myeloproliferative Neoplasm (MPN) Patients with Claire Harrison, MD image

ASH 2024 Highlights for Myeloproliferative Neoplasm (MPN) Patients with Claire Harrison, MD

event Feb 13, 2025 / 11:00AM EST
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

This podcast episode is meant to bring the latest research presented for MPN patients at the American Society of Hematology Conference and features special guest Claire Harrison, MD

Schedule & Agenda

The panelist Dalton Bean
11:00 AM
Introductions
Dalton Bean

Dalton introduces the agenda of the event and our featured speaker Claire Harrison, MD, FRCP, FRCPath

The panelist Claire Harrison, MD, FRCP, FRCPath
1:05 PM
Discussion with Dr. Claire Harrison
Claire Harrison, MD, FRCP, FRCPath

Speakers & Moderators

The panelist Dalton Bean
Dalton Bean
Lehi, UT

Dalton joined HealthTree in 2024 as the CLL and MF Education Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.

Read Bio
The panelist Claire Harrison, MD, FRCP, FRCPath
Claire Harrison, MD, FRCP, FRCPath

Professor Claire Harrison graduated from Oxford Univeristy Medical School and became a consultant at the Guy’s and St Thomas Hospital in 2001, where she is now a deputy chief medical officer. The focus of her clinical work is myeloproliferative neoplasms (MPN), for which she has a national and international reputation. Key areas of interest are clinical trials and associated translational research. Her work has led to the approval of new therapies such a ruxolitinib, fedratinib, momelotinib and pacritinib. In the past 10 years she has published widely (>300 academic articles). In addition she has a strong interest in patient advocacy and founded the UK MPN group www.mpnvoice.org.uk.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Myeloproliferative Neoplasm Discussion group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
GSK
Regeneron